bf/NASDAQ:DYN_icon.png

NASDAQ:DYN

Dyne Therapeutics

  • Stock

USD

Last Close

18.20

06/11 21:47

Market Cap

3.87B

Beta: 0.24

Volume Today

1.59M

Avg: 383.32K

PE Ratio

−6.54

PFCF: −7.34

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
1.47B
-
842M
42.56%
1.37B
62.23%
506M
62.96%
cost of revenue
1.15B
-
2.03B
77.12%
2.28B
12.48%
2.93B
28.54%
2.46M
-
gross profit
321M
-
-1.19B
469.47%
-915M
22.85%
-2.43B
165.14%
-2.46M
-
selling and marketing expenses
-2.46M
-
general and administrative expenses
-97M
-
128M
231.96%
161M
25.78%
189M
17.39%
517K
99.73%
2.79M
438.88%
13.45M
382.66%
28.72M
113.56%
28.20M
1.79%
31.40M
11.34%
62.48M
98.98%
selling general and administrative expenses
-97M
-
128M
231.96%
161M
25.78%
189M
17.39%
517K
99.73%
2.79M
438.88%
13.45M
382.66%
28.72M
113.56%
28.20M
1.79%
28.94M
2.61%
62.48M
115.90%
research and development expenses
4.28M
-
11.04M
158.06%
45.20M
309.42%
121.31M
168.38%
142.76M
17.68%
210.76M
47.63%
281.41M
33.52%
other expenses
-211M
-
-21K
-
-1.32M
6,200%
-790K
40.29%
-8K
98.99%
2.86M
35,887.50%
cost and expenses
837M
-
2.16B
157.59%
2.44B
13.27%
3.12B
27.81%
4.79M
99.85%
13.83M
188.34%
58.65M
324.18%
150.03M
155.81%
170.96M
13.96%
242.16M
41.65%
operating expenses
-308M
-
128M
141.56%
161M
25.78%
189M
17.39%
4.79M
97.46%
13.83M
188.34%
58.65M
324.18%
150.03M
155.81%
170.96M
13.96%
239.70M
40.21%
343.89M
43.46%
interest expense
67M
-
546M
714.93%
625M
14.47%
616M
1.44%
5K
100.00%
396K
-
2.92M
-
ebitda
292M
-
736M
152.05%
106M
85.60%
949M
795.28%
-4.79M
100.50%
-14.59M
204.74%
-58.65M
302.02%
-148.20M
152.70%
-170.96M
15.36%
-239.70M
40.21%
-315.18M
31.49%
operating income
-318M
-
64M
120.13%
-640M
1,100%
-412M
35.63%
-4.79M
98.84%
-13.83M
188.34%
-58.65M
324.18%
-150.03M
155.81%
-170.96M
13.96%
-242.16M
41.65%
-343.89M
42.01%
depreciation and amortization
292M
-
614M
110.27%
766M
24.76%
867M
13.19%
24K
100.00%
-762K
3,275%
700K
191.86%
1.82M
160.29%
1.68M
7.63%
2.46M
46.23%
2.24M
8.86%
total other income expenses net
50M
-
-491M
1,082%
-649M
32.18%
-126M
80.59%
-21K
99.98%
-1.03M
4,819.05%
-790K
23.52%
734K
192.91%
2.86M
290.05%
6.22M
117.43%
26.47M
325.19%
income before tax
-268M
-
-427M
59.33%
-1.29B
201.87%
-538M
58.26%
-4.81M
99.11%
-14.86M
208.85%
-59.44M
300.01%
-149.29M
151.18%
-168.10M
12.60%
-235.94M
40.36%
-317.42M
34.54%
income tax expense
117M
-
-474M
505.13%
-45M
90.51%
-610M
1,255.56%
-11K
100.00%
-1.32M
11,927.27%
-700K
47.09%
-8K
98.86%
-2.86M
35,675%
net income
-67M
-
50M
174.63%
-1.24B
2,580%
76M
106.13%
-4.81M
106.33%
-13.54M
181.36%
-58.74M
333.93%
-149.28M
154.15%
-165.24M
10.69%
-235.94M
42.79%
-317.42M
34.54%
weighted average shs out
126M
-
125M
0.79%
129M
3.20%
162M
25.58%
10.32M
93.63%
12.82M
24.15%
14.40M
12.31%
50.90M
253.54%
51.98M
2.12%
59.68M
14.83%
94.14M
57.74%
weighted average shs out dil
126M
-
126M
0%
129M
2.38%
162M
25.58%
10.32M
93.63%
12.82M
24.15%
14.40M
12.31%
50.90M
253.54%
51.98M
2.12%
59.68M
14.83%
94.14M
57.74%
eps
-0.53
-
0.40
175.47%
-9.61
2,502.50%
0.47
104.89%
-0.47
200%
-1.06
125.53%
-4.08
284.91%
-2.93
28.19%
-3.18
8.53%
-3.95
24.21%
-3.37
14.68%
epsdiluted
-0.53
-
0.40
175.47%
-9.61
2,502.50%
0.47
104.89%
-0.47
200%
-1.06
125.53%
-4.08
284.91%
-2.93
28.19%
-3.18
8.53%
-3.95
24.21%
-3.37
14.68%

All numbers in USD (except ratios and percentages)